Patel Sanjiv's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Feb 13, 2025
- Accession no.
- 0000950170-25-020272
- Filed
- Feb 13, 2025
- Trade date
- Feb 11-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $818.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel SanjivCIK 0001816210 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | SSaleDisposed | −140,182 | $3.85 | −$539,700.7 | 625,948 | Direct | |
| Feb 11, 2025 | Common Stock | AGrant or awardAcquired | +332,465 | $0.00 | $0 | 958,413 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −75,324 | $3.70 | −$278,698.8 | 883,089 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.